We have previously shown that tumor necrosis factor (TNF)a strongly potentiates the granulocyte-macrophage colony-stimulating factor (GM-CSF)/interleukin (IL)-3-dependent proliferation of CD34+ hematopoietic progenitor cells IHPC) through the recruitment of early progenitors with high proliferative potential. Furthermore, the combination of GM-CSF and TNFa allows the generation of large numbers of dendritic/Langerhans cells (D-LC). Herein, we analyzed whether IL-3, when combined t o TNFa would, as does GM-CSF, allow the generation of CDla+ D-LC. Accordingly, cultures of cord blood CD34+ HPC with IL-3 + TNFa yielded 209'0 t o 609'0 CD14+ cells and 11% t o 17% CDla' cells, while IL-3 alone did not generate significant numbers of CDla+ cells. Although the percentage of CDla+ cells detected in IL-3 + TNFa was lower than that observed in GM-CSF + TNFa (429'0 t o 789' 0). the strong growth induced by IL-3 + TNFa ENDRITIC CELLS (DC) comprise a system of highly efficient antigen presenting cells that initiate immune responses such as the sensitization of major histocompatibility complex (MHC) restricted T cells and the formation of T-cell dependent antibodies.' DC are found in all organs (such as Langerhans cells in the epidermis) and after antigen capture, they migrate through the afferent lymph to lymphoid organs (interdigitating cells) where they efficiently present antigen to T CD 1 a is a marker for epidermal Langerhans cells (LC), but more mature interdigitating cells lack CDla.' Although early reports described the bone marrow origin of DC:,6 progress concerning their site of development and the condition that direct their growth and differentiation have emerged only recently. In the past few years, several reports have described the central role of granulocyte-macrophage colony-stimulating factor (GM-CSF) in the development of dendritic Langerhans cells from hematopoietic progenitor^.^"^ GM-CSF is produced by numerous cell types including fibroblasts, keratinocytes, monocytes, and T lymphocytes.'$ In contrast, the production of interleukin (1L)-3 is restricted to antigen stimulated T cells, activated mast cells, and keratinocytes." However, IL-3 and GM-CSF share several activities on myelopoiesis and permit CD34+ hematopoietic progenitor cells (HPC) to mature into granulocytes, monocytes, erythrocytes, and megakaryocyte^.'^.'' Also both IL-3 and GM-CSF act on mature hematopoietic cells such as mono- 
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cytes, eosinophils, and
However, IL-3 seems to possess unique functions on B-cell lymphopoiesis,'"'' as well as antigen-dependent mature B-cell growth and differentiati~n.",~" Conversely, GM-CSF appears to display activities not shared by IL-3 on neutrophil activation," as well as Langerhans cell mat~ration.~'.~' Thus, in the present study, we investigated whether the generation of D-LC from cord blood CD34' HPC was restricted to GM-CSF. We found that, when combined with tumor necrosis factor (TNF)a. IL-3 induced cord blood CD34' to develop into CDla' D-LC similar in morphology, phenotype, and function to those generated in the presence of GM-CSF + TNFa.
MATERIALS AND METHODS
Hematopoietic jactors. rhGM-CSF (specific activity:
2. IO" U/ mg, Schering-Plough Research Institute, Kenilworth, NJ) was used at a saturating concentration of 100 ng/mL (200 U/mL). rhIL-S (specific activity: S X IOh U/mg, kindly provided by Dr S. Tindall, Schering-Plough Research Institute, Kenilworth, NJ) was used at a saturating concentration of 10 ng/mL (SO U/mL).Z4 rhTNFa (specific activity: 2 X IO' Ulmg Genzyme, Boston, MA) was used at an optimal concentration of 2.5 ng/mL (50 U/mL).?5
Collection and purijcation of cord blood CD34' HPC. Umbilical cord blood samples were obtained according to institutional guidelines. Cells bearing the CD34 antigen were isolated from nonadherent mononuclear fractions through positive selection by indirect immune "panning" using anti-CD34 monoclonal antibody (MoAb) (Immu-133.3, Immunotech, Marseille, France). A second purification step was performed using a cocktail of MoAbs and immunomagnetic beads (Dynabeads M450, Dynal, Oslo, Norway), as described." Thus, in all experiments, the isolated cells were 9S% to 99% CD34' as judged by staining with anti-CD34 MoAb.
Purijcation of peripheral blood dendritic cells and monocytes. Dendritic cells, isolated from peripheral blood following the protocol of Freudenthal and Steinman," were used as a standard population of dendritic cells. Briefly, peripheral blood mononuclear cells were depleted of T cells by rosetting with sheep erythrocytes followed by Ficoll-Hypaque sedimentation, and cultured at 3 X 106 cells per mL at 37°C for 36 hours. After culture, monocytes were removed by two serial 30 to 40 minute adherence steps at 37°C. To recover the adherent monocytes, the dishes were washed three times and For personal use only. on November 16, 2017. by guest www.bloodjournal.org From cultured with fresh medium for 3 to 4 hours, at which point the monocytes were easily dislodged. The monocyte and T-cell depleted fraction (5 X IO6 cells per mL) was layered onto hypertonic 14.5% metrizamide columns and sedimented at 650g for 10 minutes. The dendritic cell enriched interface was returned to isotonicity after two successive washes with 40 and 25 mmol/L NaCl complete medium solutions. The enriched population representing 0.3% to 0.9% of the starting mononuclear cells was composed of 45% to 75% dendritic cells as judged by morphology and high MHC class I1 expression and lack of CD14, CD19, and CD16 expression. The major other cells were CD14' monocytes.
Pur$cation of adult peripheral blood CD4' T cells. Mononuclear cells were isolated from adult peripheral blood and depleted of adherent cells by overnight adherence to plastic, in complete medium (see below), at 1 X lo6 cellslml. CD4' T lymphocytes were then purified by immunomagnetic depletion using a cocktail of MoAbs IOM2 (CD14), ION16 (CD16), ION2 (HLA-DR) (Immunotech, Marseille, France), NKHl (CD56), OKT8 (CD8) (Ortho Diagnostic System, Raritan, NJ), 4G7 (CD19) and MoAb 89 (CD40).*' After two rounds of bead depletion, the purity of CD4' T cells was routinely higher than 95%.
Cell cultures in liquid medium of CD34' HPC. Cultures were established in the presence of GM-CSF or L 3 with or without TNFa in endotoxin free medium consisting of RPMI 1640 (GIBCO, Grand Island, NY) supplemented with 10% (vol/vol) heat-inactivated fetal bovine serum (FBS; Flow Laboratories, Imine, UK), 10 mmol/L HEPES, 2 mmol/L L-glutamine, 5 X lo-' m o m 2-mercaptoethanol, penicillin (100 U/mL), and streptomycin (100 pg/mL; referred to as complete medium).
CD34' cells were seeded for expansion in 24-well culture-plates (Linbro; Flow Laboratories, McLean, VA) at 2 X l@ celldmL. Optimal conditions were maintained by splitting these cultures every 4 to 5 days with medium containing fresh factors (cell concentration: 1 to 3 x LO' cells/mL). Cells were routinely collected after 12 days of culture, eventually adherent cells were recovered using a ~-mmov L EDTA solution.
Cytojuorimetric cell-surface phenotyping. Indirect immunofluorescence was performed according to standard techniques, using a panel of murine MoAbs shown by phycoerythrin (PE)-conjugated sheep F (ab')? antimouse Igs (Ortho). Double-color fluorescence was performed by sequential incubation of the cells with unconjugated MoAbs, PE-conjugated antimouse Igs, normal mouse serum, and OKT6 (CDla) (Ortho) or Leu-M3 (CD14) (Becton Dickinson, Sunnyvale, CA) MoAbs directly labelled with fluorescein isothiocyanate (FITC). Negative controls were performed with unrelated murine MoAbs. Fluorescence analysis was determined with a FACScan flow-cytometer (laser setting: power, 15 mW, excitation wavelength 488 nm, Becton Dickinson), and 10,000 to 50,000 events were collected for double staining.
Fluorescence-activated cell sorter (FACS). For certain experiments, cells generated from CD34' HPC after 12 days of culture in the presence of GM-CSF, GM-CSF + TNFa, or IL-3 + TNFa, were collected and labelled with FITC-conjugated OKT6 (CDla) (Ortho) and PE-conjugated Leu-M3 (CD14) (Becton Dickinson). Cells were separated according to CDla and CD14 expression into CDla-CD14' and CDla' CD14-fractions using a FACStarplus (laser setting: power, 250 mW, excitation wavelength 488 nm, Becton Dickinson). The procedure of staining and sorting was performed in the presence of 5 mmol/L EDTA to avoid cell aggregation. Reanalysis of the sorted populations showed a purity higher than 98%.
T-cell proliferation assay. After 12 days of culture, CD34+ HPC derived cells were collected and, after irradiation (30 Gy), used as stimulator cells for resting allogeneic adult peripheral blood CD4+ T cells (2.5 X IO4 per well). From 10 to IO4 stimulator cells were added to the T cells in 96-well round-bottomed microtest tissueculture plates (Nunc, Roskilde, Denmark). Cultures were performed in RPMI 1640 medium supplemented with 10% heat inactivated human AB+ serum, glutamine, and antibiotics as above. After 5 days incubation, cells were pulsed with 1 pCi of 'H-TdR (specific activity 25 Ci/mmol) per well, for the last 8 hours, harvested, and counted. Tests were performed in triplicate and results were expressed as mean counts per minute (cpm). Standard deviations were always below 10%. The levels of thymidine uptake by stimulator cells alone were always below 100 cpm.
RESULTS

When combined with TNFa, IL-3, as well as GM-CSF, can induce CD34' HPC to difSerentiate into CDla+ D-LC.
We have recently shown that TNFa directs the GM-CSFdependent development of CD34' W C toward the DC lineage characterized by the expression of the CDla antigen. As TNFa was also found to synergize with IL-3 to induce the growthlmaturation of cord blood CD34+ HPC,25,28 we wondered whether IL-3 would, as GM-CSF, allow the generation of CDla' D-LC. Although among DC, CDla expression is restricted to Langerhans cells, CDla remains the best antigen available allowing the identification of DC derived from CD34 HPC. As previously de~cribed,'~ mainly CD15' granulocytic cells (range, 31% to 72%, n = 6) were generated in the presence of IL-3 alone, while CD14' cells (33%, range, 22% to 63%, n = 6) represented the major population after culture in the presence of IL-3 + TNFa (Fig 1) . In addition, the subset of cells expressing the CDla antigen, barely detectable in presence of IL-3 alone (54%) represented 14% (range, 11% to 17%, n = 6) in the presence of IL-3 + TNFa. As a comparison, GM-CSF alone allowed strong development of CD14+ cells (47%, range, 35% to 61%, n = lo), which is not observed in GM-CSF + TNFa (15%, range, 11% to 25%, n = 10). Conversely, the major development of CDla' cells (47%, range, 42% to 78%, n = 10) seen in GM-CSF + TNFa was not detected in GM-CSF alone (sa, range, 7% to 15%, n = 10). Furthermore, 73% (range, 67% to 73%, n = 10) and 86% (range, 70% to 90%, n = 10) of the cells expressing the CDla antigen in IL-3 + TNFa and GM-CSF + TNFa, respectively, did not bear the CD14 antigen. In terms of morphology, as observed following May-Griinwald-Giemsa staining, after 12 days of culture, no D-LC could be detected within cells generated in IL-3 alone, while in the presence of IL-3 + TNFa 8.0% t CD14 expression, and a large proportion of those cells can also express CDla. The low frequency of these cells did not permit their full characterization. Rather, the CD14' cells. which represent a major population in GM-CSF cultures, are mostly CD I a-and could be fully characterized. CD I4'CD 1 afrom IL-3 + TNFa or GM-CSF cultures and CD14-CDla' cells from IL-3 + TNFa or GM-CSF + TNFa cultures. were FACS-sorted and analyzed for morphology. As shown in Fig   2, CD14 'CDla-cells generated either in IL-3 + TNFa or GM-CSF alone appeared as small regularly shaped monocytes (Figs 2A and B) , while CD14-CDla' cells generated either in IL-3 + TNFa or GM-CSF + TNFa represented an homogeneous population of large cells displaying a characteristic dendritic morphology (Figs 2C and D) .
The phenotype, determined by two-color analysis, of the CD14' and of the CDla' generated in GM-CSF alone and GM-CSF + TNFa. respectively, was compared with that of CD14' and CDla' cells generated in IL-3 + TNFa. Cells cultured for 12 days with either GM-CSF, GM-CSF + TNFa, or IL-3 + TNFa were initially stained using a panel of unlabelled MoAbs shown with PE coupled antimouse Ig, then, after saturation in mouse serum. labelled with FlTC coupled CD14 or CDla. Figure 3 shows the flow cytometry histograms of antibody staining gated on the CDla' cells (in white) and on the CD14' cells (in black). Differences in phenotype between CD14' and CDla' cells generated in 1L-3 + TNFa were similar to those observed between CD14' and CDla' cells generated in GM-CSF alone and GM-CSF + TNFa, respectively. Between IO% to 30% of CDla" cells expressed CD14 and less than 10% of CD14' expressed CDla. CD1 b was weakly expressed on both subsets, while CDlc was mainly expressed on CDla' cells. While the FCy receptor RI11 (CD1 6) was weakly expressed on both cell types, the FCy RI1 (CD32) was highly expressed on both CDla' and CD14' cells, and the FCy RI (CD@) was only expressed on CD14' cells. While the complement receptor CR2 (CD21 ) was nerative on both cell types, the CR3 (CD I I b) and the CR I (CD3S) were only expressed on
For CD14' cells. Concerning adhesion molecules, while the a chain of the LFA I (CD I I a) was expressed at a similar density on both populations, the p chain (CD1 8) was expressed at higher levels on CD14' cells. In contrast, the level of expression of the ligand for leukocyte function-associated I antigen (LFAI), intracellular adhesion molecule (ICAM 1) (CD54) was much higher on CDla' cells. LFA3 (CD58) and CD1 I C were also expressed at higher levels on CD1 a+ cells. CD4 and CD40 were expressed on both subsets, but the level of expression was higher on CDla' cells. Finally, HLA class 11, CD80, and CD86 molecules were more strongly expressed on CD la+ cells generated in GM-CSF + TNFa than on CDla' cells generated in IL-3 + TNFa.
However, whatever the culture conditions, the levels of HLA class I1 molecules were 10 to 50-fold higher, that of CD80 (B7/BB-I) 5 to 15-fold higher, and that of CD86 (B70/B7-2) I O to 20-fold higher on CD 1 a+ cells than on CD 14' cells.
Thus, the CDla' cells generated in the presence of IL-3 + TNFa are similar in morphology and phenotype to those obtained in the presence of GM-CSF + TNFa.
CDla' D-LC generated with IL-3 + TNFa are a strong inducer of alloreactive T-cell proliferation.
As D-LC are potent stimulators of allogeneic T-cell proliferation, we assayed CD34' HPC cultured for 12 days in these different conditions for their capacity to induce proliferation of resting allogeneic CD4' T cells (Fig 4) . As shown in Fig 4A, bulk progeny generated in the presence of GM-CSF + TNFa was a much stronger potentiator of allogeneic CD4' T-cell proliferation than cells arising from HPC cultured in GM-CSF alone. Similarly, although less potent than GM-CSF + TNFa progeny, bulk progeny generated in IL-3 + TNFa was a fairly strong inducer of allogeneic T-cell proliferation compared with that generated in IL-3 alone. ' H TdR incorporation of 2.5 X 10' CD4' T cells is increased 50-fold by 1.5 X IO' cells (0.68 to 2.4 X IO3) generated in IL-3 + TNFa, 6.5 X 10' cells ( I to 8 X IO') generated in GM-CSF, and 100 cells (40 to 250) generated in GM-CSF + TNFa (means and ranges from five experiments). Bulk progeny generated in the presence of GM-CSF + TNFa were compared with a 45% to 75% enriched population of DC isolated from adult peripheral blood (PBL DC) using the protocol of Freudenthal and Steinman.'" As shown in Fig 4B, cells generated in IL-3 + TNFa, CD14-CDla' cells appeared to be SO to 100 times more efficient than CD 14' CD1 a-cells, and 200 to 1,000 times than CD14-CDlacells in inducing proliferation of resting alloreactive CD4' T cells (Fig SA) . ' H TdR incorporation of 2.5 X 10' CD4' T cells was increased SO-fold by 37 CD14-CD1 a+ cells (range, 12 to 60) or by 2 X IO' CD 14' CD 1 a-cells (range. 1 X IO'to S X IO'). Similarly, as few as 30CD14-CDla" D-LC, FACS-sorted from GM-CSF + TNFa cultures induced a strong proliferation of allogeneic CD4' T cells, while CD 14' CDla-cells, FACS-sorted from GM-CSF cultures, were fairly poor antigen presenting cells (Fig SB) as monocytes purified from peripheral blood (Fig 4B) .
Thus, when combined with either IL-3 or GM-CSF, TNFa is able to induce the development of functional CDla' D-LC.
When combined with TNFcu, IL-3 yields CIS many viable CDla' D-LC as does GM-CSF. As IL-3 is a better inducer of CD34' HPC growth,25 ( Fig 6A) than is GM-CSF, the overall yield of CDla' D-LC was followed in cultures performed with or without TNFa. As shown in Fig 6B , CDla' cells could be detected from day 6 to day 20 in IL-3 + TNFa cultures of CD34' HPC. As previously mentioned (Fig l ) . whereas less than 4% of CD1 a + cells were observed in the presence of 1L-3,7% to I S% CD I a+ cells were detected with GM-CSF. A higher proportion of CDla' cells was detected with IL-3 + TNFa ( 1 1% to 17%) and particularly with GM-CSF + TNFa (47% to 78%) (ranges from I O experiments after 12 days of culture) (Fig 6B) . In terms of overall cell yield (Fig 6A) , IL-3 + TNFa is twofold to threefold more potent than either IL-3 alone or GM-CSF + TNFa, conditions that are themselves threefold to fourfold more efficient than GM-CSF alone. Thus, as shown in Fig 6C. CD34' HPC, in the presence of IL-3 or GM-CSF alone allowed. after 12 days of culture, the generation of 1 X 10' to 3 X IO5 CDla' cells. while those performed with 1L-3 + TNFa or GM-CSF + TNFa yielded 2 to 3 X IO"
CDla' cells (ranges from IO experiments) (Fig 6C) .
For However, mice with a disrupted GM-CSF gene have been reported to have DC and Langerhans cells in normal numbers:* suggesting that other factors, eg, IL-3, can substitute for GM-CSF. However, IL-3 has not been reported to activate mature Langerhans cells or DC, suggesting a potential loss of the IL-3 receptor a chain during DC maturation.
The redundancy of the activity of L -3 and GM-CSF, strengthened by our observations on D-LC development, is not unique and is also observed with IL-4 and L-1349 or TNFa and TNF/3.50.5' Whereas GM-CSF is produced by many cell types including fibroblasts, keratinocytes, mono- cytes, and T lymphocytes, the production of IL-3 is restricted to antigen stimulated T cells, activated mast cells, and keratinocytes.14." Therefore, IL-3 is supposed to play a major role in antigen-induced hematopoiesis, while GM-CSF might predominantly be involved in constitutive hematopoiesis. As DC represent key cells involved in antigen specific immunity, their development during an ongoing immune response under the production of L -3 (or GM-CSF), and TNFa by activated T cells or mastocytes might be crucial. 
